menu
    • menu

    Company profile for Lykos Therapeutics

    NEW Drugs in Dev: 3
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Lykos Therapeutics, a for-profit public benefit corporation, is dedicated to transforming the way mental health is treated. Established in 2014 by the non-profit Multidisciplinary Association for Psychedelic Studies (MAPS), Lykos Therapeutics aims to challenge the status quo by developing novel therapies and therapeutic approaches for mental health conditions. With over 30 years of experience in researching psychedelic-assiste...
    Lykos Therapeutics, a for-profit public benefit corporation, is dedicated to transforming the way mental health is treated. Established in 2014 by the non-profit Multidisciplinary Association for Psychedelic Studies (MAPS), Lykos Therapeutics aims to challenge the status quo by developing novel therapies and therapeutic approaches for mental health conditions. With over 30 years of experience in researching psychedelic-assisted therapies, the company remains committed to rigorous science to develop and commercialize innovative treatment options.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Lykos TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    San Jose, California 95117
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://lykospbc.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/lykos-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Lykos_PBC

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    SCOPE Summit

    SCOPE Summit

    Not Confirmed

    envelop Contact Supplier

    SCOPE Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Compass, Definium Prepare For Psychedelics Approval Filing
    Compass, Definium Prepare For Psychedelics Approval Filing

    02 Feb 2026

    // BIOSPACE

    https://www.biospace.com/drug-development/psychedelics-space-at-a-tipping-point-as-compass-definium-gear-up-to-file-for-approval

    BIOSPACE
    02 Feb 2026
    Share Share
    Lykos MDMA Rejection Letter Released, MAPS Founder Criticizes
    Lykos MDMA Rejection Letter Released, MAPS Founder Criticizes

    05 Sep 2025

    // BIOSPACE

    https://www.biospace.com/drug-development/with-lykos-mdma-rejection-letter-out-maps-founder-decries-change-of-the-goal-posts

    BIOSPACE
    05 Sep 2025
    Share Share
    MAPS Issues Statement on FDA CRL for MDMA Therapy
    MAPS Issues Statement on FDA CRL for MDMA Therapy

    04 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/05/3145062/0/en/MAPS-Statement-on-FDA-s-Public-Release-of-Complete-Response-Letter-for-MDMA-assisted-Therapy.html

    GLOBENEWSWIRE
    04 Sep 2025
    Share Share
    MAPS Searches For New Executive Director To Boost Advocacy Efforts
    MAPS Searches For New Executive Director To Boost Advocacy Efforts

    12 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/12/3025040/0/en/MAPS-Announces-Search-for-New-Executive-Director-as-it-Doubles-Down-on-Advocacy-and-Movement-Building.html

    GLOBENEWSWIRE
    12 Feb 2025
    Share Share
    Lykos still plotting path to approval for rejected MDMA therapy
    Lykos still plotting path to approval for rejected MDMA therapy

    18 Jan 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/lykos-still-plotting-path-approval-rejected-mdma-therapy-after-productive-fda-meeting

    FIERCE BIOTECH
    18 Jan 2025
    Share Share
    Lykos Loses Five Board Directors After FDA Rejection
    Lykos Loses Five Board Directors After FDA Rejection

    16 Jan 2025

    // BIOSPACE

    https://www.biospace.com/business/lykos-loses-five-board-directors-after-fda-rejection

    BIOSPACE
    16 Jan 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search